- Bitcoin analyst endorses Polygon (MATIC) as undervalued; predicts double-digit surge.
- Doctor Profit’s recommendation spurs quick growth; MATIC hits $1.04 in hours.
- Enthusiastic response as Doctor Profit endorses MATIC; community anticipates big gains.
Renowned bitcoin analyst Doctor Profit, celebrated for accurate predictions in the crypto space, has turned the spotlight on Polygon (MATIC). He labels it as one of the most undervalued projects currently available. In a recent post, he urged followers to consider entering the market, emphasizing that MATIC, is still a gift below the $1 mark.
$MATIC is one of the most undervalued projects out there. If I wouldnt have bought tons of it at $0.50 I would heavily enter now as anything below $1 is a gift
— Doctor Profit 🇨🇭 (@DrProfitCrypto) December 26, 2023
Sooner or later its an easy double digit coin in the incoming bull. One of my favorite coins
According to Doctor Profit, MATIC is poised for a significant surge in the upcoming bullish trend, predicting it to be an easy double-digit coin. Notably, his endorsement seems to have had an immediate impact, as MATIC’s price has already surpassed the $1 mark in less than 24 hours.
The analyst suggests that those who missed the opportunity to acquire MATIC at $0.50 should seriously consider entering the market now, as he foresees substantial growth in the near future. Drawing on his past successful predictions, investors are looking to capitalize on MATIC’s potential rise.
In response to Doctor Profit’s endorsement, the crypto community has been vocal about holding MATIC and expressing optimism about its rapid ascent. Similar comments were made about Polkadot (DOT) and its ongoing rise as well.
Additionally, the discussion expanded to other cryptos that have witnessed impressive growth. Examples include AVAX, surging from $9 to $50; SOL, catapulting from $8 to $120; INJ, rising from $1.10 to $45; FET, increasing from $0.05 to $0.75; and LINK, escalating from $4.90 to $17.00.
As the crypto market continues its dynamic trajectory, followers eagerly anticipate how MATIC, backed by Doctor Profit’s endorsement, will fare in the evolving landscape. The community remains watchful, prepared for potential surges based on the analyst’s track record.